Australian Friedreich Ataxia Stem Cell and Gene Therapy Consortium
- Project status: Active
Research area: Genetics > Genetic Health (BLC)
The Consortium’s vision is to facilitate and undertake Friedreich ataxia cell and gene therapy clinical trials leading to successful outcomes for patients as soon as possible.
The Consortium is a strategic alliance of pre-eminent experts in Friedreich Ataxia, Stem Cells, Gene Therapy, Policy, Advocacy and Regulation. Please support the Australian Friedreich Ataxia Stem Cell and Gene Therapy Consortium.
The Consortium is a strategic alliance of pre-eminent experts in Friedreich Ataxia, Stem Cells, Gene Therapy, Policy, Advocacy and Regulation. Please support the Australian Friedreich Ataxia Stem Cell and Gene Therapy Consortium.
Overview
The Consortium has been assembled by the Murdoch Children’s Research Institute to develop strategies and undertake programs that will expedite Friedreich Ataxia cell and gene therapy clinical trial readiness and translation in Australia and internationally.
Our purpose
Currently, there are no approved treatments or cure for Friedreich Ataxia.
- 1 in 30,000 people in Australia are born with Friedreich Ataxia.
- 1 in 90 unaffected people are carriers of a faulty Friedreich Ataxia gene.
At least seven companies and/or academic institutions are currently developing gene therapies for Friedreich Ataxia. Murdoch Children’s Research Institute is the Australian Collaborative Clinical Research Network (CCRN) in FA site and is preparing to be the Australian site for Australia’s first approved Friedreich Ataxia gene therapy clinical trials.
What’s involved
- Establishment of FA Gene Therapy Readiness at the Murdoch Children’s Research Institute.
- A Consortium Advisory Board meets regularly and provides expertise and guidance on accelerating progress towards FA cell and gene therapy clinical trial readiness and translation.
- The Australian and international FA research community attends an annual FA Stem Cell and Gene Therapy Colloquium and helps advance research and fill key gaps.
- Consortium-directed research projects include vector development, qualitative study of patient and family views of gene therapy trials and outcome measure selection.
- An International Consortium for FA Gene Therapy Readiness that includes key stakeholders in clinical research sites, pharma and biotech industry partners, regulatory authorities and patient education and informed consent.
Information for participants
We are committed to fast-tracking FA cell and gene therapy clinical trials in Australia for all individuals with FA. Here are some ways you can get involved
- Join the FA Global Patient Registry
Contact us
Contact us for more information about our research and clinical trials.
Australian Friedreich Ataxia Stem Cell and Gene Therapy Consortium
Murdoch Children's Research Institute
The Royal Children's Hospital
50 Flemington Road
Parkville VIC 3052
Australia
FA Clinical Research Database
Email:
show email address
Sign up for our mailing list
Email:
show email address
Genetic screening newsroom
Study tracking a generation’s health still open to eligible families as it enters new phase
Newborn recruitment has closed for a world-first study that is tracking the health of an entire...
Accolade for international collaboration working to better treat childhood conditions
An international collaboration aiming to better treat rare and serious childhood illnesses has...
New WHO Genomics Group appoints Australian Genomics Managing Director Tiffany Boughtwood
Murdoch Children’s Research Institute researcher and Australian Genomics Managing Director...
World-first child health study reaches recruitment milestone
A world-first study tracking the health and wellbeing of Victorians, from birth to old age, has...
Early Years Summit a welcome focus on Australian children
Murdoch Children’s Research Institute was a key participant in the Albanese Government’s...
Federal funding for genomics projects aiming to improve child health
Two researchers from Murdoch Children’s Research Institute (MCRI) and Victorian Clinical...
prepair™ genetic carrier screening: Q&A with Associate Genetic Counsellor Dr Alison Archibald
The Victorian Clinical Genetics Services (VCGS) is a not-for-profit provider of genetic tests...
Genetic carrier screening should be recommended for all couples planning a family
Testing for Down syndrome has been routinely offered for over twenty years, yet most health care...
Share //
